dextrothyroxine has been researched along with sildenafil citrate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alves, FA; Araujo, JP; Jaguar, GC | 1 |
| Freeman, PR; Horowitz, RI | 1 |
2 other study(ies) available for dextrothyroxine and sildenafil citrate
| Article | Year |
|---|---|
Syphilis related to atypical oral lesions affecting an elderly man. a case report.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Cardiolipins; Cholesterol; Diagnostic Errors; Erectile Dysfunction; Fluorescent Treponemal Antibody-Absorption Test; Humans; Insecticides; Ivermectin; Male; Mouth; Penicillin G Benzathine; Phosphatidylcholines; Scabies; Sildenafil Citrate; Stomatitis, Herpetic; Syphilis; Unsafe Sex; Urological Agents | 2015 |
Three novel prevention, diagnostic, and treatment options for COVID-19 urgently necessitating controlled randomized trials.
Topics: Acetazolamide; Anti-Inflammatory Agents; Anticoagulants; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Diet Therapy; Humans; Immune System; Inflammation; Ivermectin; Mass Screening; NF-E2-Related Factor 2; NF-kappa B; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; Resource Allocation; Risk; Sildenafil Citrate; Treatment Outcome | 2020 |